MLSS (Milestone Scientific) Days Sales Outstanding: 25.04 (As of Jun. 2026) — 58% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MLSS Milestone Scientific Inc MLSS
37 GF Score
Price $0.50
GF Value $0.60
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Milestone Scientific Days Sales Outstanding?

Milestone Scientific MLSS -10.47% 37 Days Sales Outstanding is 25.04 as of Jun. 2026, which is 58% below its 10-year median of 59.21. GuruFocus rates MLSS with a GF Score™ of 37/100 and a GF Value™ of $0.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Milestone Scientific ranks better than 92.84% on this metric.

Milestone Scientific's average Accounts Receivable for the three months ended in Jun. 2026 was $0.78 Mil. Milestone Scientific's Revenue for the three months ended in Jun. 2026 was $2.84 Mil. Hence, Milestone Scientific's Days Sales Outstanding for the three months ended in Jun. 2026 was 25.04.

The historical rank and industry rank for Milestone Scientific's Days Sales Outstanding or its related term are showing as below:

MLSS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.66   Med: 59.21   Max: 109.64
Current: 28.14

During the past 13 years, Milestone Scientific's highest Days Sales Outstanding was 109.64. The lowest was 16.66. And the median was 59.21.

MLSS's Days Sales Outstanding is ranked better than
92.84% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: 65.165 vs MLSS: 28.14

Milestone Scientific's Days Sales Outstanding increased from Jun. 2025 (23.63) to Jun. 2026 (25.04).


Milestone Scientific  (AMEX:MLSS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Milestone Scientific Days Sales Outstanding Related Terms


Milestone Scientific Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Milestone Scientific's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milestone Scientific Days Sales Outstanding Chart

Milestone Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.84 33.93 18.70 16.66 23.51

Milestone Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.63 26.89 30.77 26.10 25.04

MLSS vs NEPH, HBIO, POCI: Days Sales Outstanding Comparison

For the Medical Instruments & Supplies subindustry, Milestone Scientific's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Milestone Scientific Days Sales Outstanding vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Milestone Scientific's Days Sales Outstanding falls into.


MLSS
37GF Score
Milestone Scientific Inc MLSS
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Milestone Scientific Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Milestone Scientific's Days Sales Outstanding for the fiscal year that ended in Dec. 2025 is calculated as

Days Sales Outstanding (A: Dec. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count ) / Revenue (A: Dec. 2025 )*Days in Period
=( (0.475 + 0.681) / 2 ) / 8.974*365
=0.578 / 8.974*365
=23.51

Milestone Scientific's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding (Q: Jun. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2026 ) + Accounts Receivable (A: Jun. 2026 )) / count ) / Revenue (A: Jun. 2026 )*Days in Period
=( (0.556 + 1.003) / 2 ) / 2.841*365 / 4
=0.7795 / 2.841*365 / 4
=25.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 25.04 mean?
Milestone Scientific (MLSS) has a Days Sales Outstanding of 25.04 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Milestone Scientific and its competitors. This is 58% below median its historical median of 59.21. Over the past decade, Milestone Scientific's Days Sales Outstanding has ranged from 16.66 to 109.64. According to the industry distribution chart, Milestone Scientific ranks #58 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 7.2%.
Is Milestone Scientific's Days Sales Outstanding too high?
Milestone Scientific's current Days Sales Outstanding of 25.04 is 58% below median its 10-year median of 59.21. Over the past 10 years, this metric has ranged from a low of 16.66 to a high of 109.64. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.17. Milestone Scientific's value of 25.04 is 61.6% below this industry median. Based on the distribution chart, Milestone Scientific ranks #58 out of 810 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Milestone Scientific has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Milestone Scientific's Days Sales Outstanding compare to NEPH and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Milestone Scientific ranks #58 out of 810 companies for Days Sales Outstanding. This places Milestone Scientific in the top 7% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 65.17. Milestone Scientific's value of 25.04 is 61.6% below this benchmark. Historically, Milestone Scientific's own Days Sales Outstanding has ranged from 16.66 to 109.64 over the past decade. While the company's 10-year median is 59.21 vs. the industry median of 65.17, Milestone Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.17, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Milestone Scientific's current Days Sales Outstanding of 25.04 is 61.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Milestone Scientific and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milestone Scientific's current Days Sales Outstanding is 25.04, which is 58% below median its own 10-year median of 59.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Scientific stock overvalued right now?
Based on GuruFocus' analysis, Milestone Scientific (MLSS) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.60, compared to a current price of $0.50 — trading 17.5% below its estimated fair value. The current Days Sales Outstanding is 25.04, which is 58% below median its 10-year median of 59.21 and 61.6% below the Medical Devices & Instruments industry median of 65.17. Milestone Scientific's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Milestone Scientific (MLSS), the current Days Sales Outstanding is 25.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Milestone Scientific (MLSS) Overvalued in 2026?

Based on GuruFocus' analysis, Milestone Scientific stock appears to be undervalued. The current stock price of $0.50 is trading 17.5% below its estimated GF Value™ of $0.60. GuruFocus considers Milestone Scientific to be Modestly Undervalued.

Key valuation signals for MLSS:

  • Days Sales Outstanding: 25.04 (58% below median its 10-year median of 59.21)
  • GF Value™: $0.60 vs. price of $0.50 (17.5% below fair value)
  • GF Score™: 37/100 with 3 warning signs
  • Industry Position: 61.6% below the Medical Devices & Instruments median (#58 of 810)

No single metric tells the full story. See the MLSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Milestone Scientific Business Description

Address 425 Eagle Rock Avenue, Roseland, NJ, USA, 07068
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
37GF Score

Get the complete analysis for MLSS

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.50
Price
$0.60
GF Value